ENVB
NASDAQ · Pharmaceuticals
Enveric Biosciences Inc
$1.95
-0.05 (-2.50%)
Open$1.99
Previous Close$2.00
Day High$1.99
Day Low$1.95
52W High$21.60
52W Low$1.82
Volume—
Avg Volume33.6K
Market Cap2.73M
P/E Ratio—
EPS$-89.80
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+408.2% upside
Current
$1.95
$1.95
Target
$9.91
$9.91
$5.56
$9.91 avg
$13.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 5.72B | 5.54B | 1.01M |
| Net Income | -27,451,363 | -23,905,395 | 237.2K |
| Profit Margin | -14.0% | -13.3% | 23.5% |
| EBITDA | -26,476,080 | -24,336,986 | 375.3K |
| Free Cash Flow | — | — | 127.9K |
| Rev Growth | +3.4% | +3.4% | -4.2% |
| Debt/Equity | — | — | 0.59 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |